Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (10)
  • 2025 (50)
  • 2024 (26)
  • 2023 (47)
  • 2022 (136)
  • 2021 (162)
  • 2020 (53)
  • 2019 (75)
  • 2018 (41)
  • 2017 (37)
  • 2016 (47)
  • 2015 (42)
  • 2014 (54)
  • 2013 (64)
  • 2012 (18)
  • 2011 (67)
  • 2008 (10)
  • 2007 (18)
  • 2006 (23)
  • 2005 (15)
  • 2004 (13)
  • 2003 (23)

Subject

  • Drug Trafficking (250)
  • Synthetic drugs (195)
  • Seizures (Drugs/Property) (188)
  • Task Forces/Task Force Officers (170)
  • Major Law Enforcement Operation (139)
  • Guns/Weapons (106)
  • OCDETF/Task Force (87)
  • Overdose (73)
  • Arrests/Convictions - Major (69)
  • Prescription Drugs (68)
  • Fake Pills (66)
  • Gangs (51)
  • Outreach/Drug Prevention (50)
  • Diversion Division (44)
  • Pharmaceuticals/Pharmacists/Physicians (44)
  • Narcoterrorism (41)
  • Take Back Day (36)
  • Press Conferences (32)
  • Guilty Plea (31)
  • Public and Media Affairs - also see Congressional Affairs (26)
  • Money Laundering (24)
  • One Pill Can Kill (20)
  • Fentanyl Awareness (18)
  • Prevention/Education - DEA websites GSAD, JTT etc (15)
  • Congressional Affairs (12)
  • HIDTA (10)
  • International/Foreign Operations (10)
  • Red Ribbon (9)
  • Dark Web- Internet Trafficking (8)
  • Extraditions (7)
  • Fentanyl Free America (6)
  • Intergovernmental Affairs (6)
  • Asset Forfeiture (5)
  • Counterfeit Pills (5)
  • Campaigns (3)
  • Critical Incident (3)
  • Museum and Visitors Center (3)
  • Terrorism (3)
  • Intelligence Division - Intelligence Products (2)
  • Scam Calls (2)
  • Cartel (1)
  • Other (1)

Drug Name

  • Fentanyl (200)
  • Cocaine (144)
  • Heroin (111)
  • Synthetic Opioids (93)
  • Methamphetamine (75)
  • Opioids (60)
  • Oxycodone (28)
  • Marijuana (Cannabis) (22)
  • Hydromorphone (7)
  • Benzodiazepines (6)
  • Ecstasy/MDMA (6)
  • Morphine (5)
  • K2/Spice (4)
  • Steroids (4)
  • Marijuana Concentrates (3)
  • Ketamine (2)
  • Methadone (2)
  • Synthetic Bath Salts or Designer Cathinones (2)
  • Amphetamines (1)
  • GHB (1)
  • Psilocybin (1)
  • Xylazine (1)

Field Division

  • New England (2403)
  • New York (1524)
  • Houston (915)
  • Miami (857)
  • San Francisco (849)
  • Seattle (823)
  • St. Louis (809)
  • Atlanta (786)
  • Chicago (635)
  • New Jersey (494)
  • New Orleans (490)
  • Detroit (362)
  • El Paso (354)
  • Dallas (318)
  • Los Angeles (303)
  • Phoenix (276)
  • San Diego (247)
  • Rocky Mountain (167)
  • Omaha (140)
  • Philadelphia (140)
  • Louisville (84)
  • Caribe (79)
  • Caribe (1)
  • Washington, DC (618)
  • Sede (418)
Clear All Results
1031 Results - Showing 91 to 100
PRESS RELEASE

DEA Executes Operation Bottleneck to Prevent the Diversion of Controlled Substances and Keep Communities Safe

WASHINGTON – Today, the U.S. Drug Enforcement Administration announced administrative actions against six DEA-registered companies which, together, failed to account for more than a million doses of opioids. Under DEA initiative “Operation Bottleneck,” DEA served an Immediate Suspension Order and five Orders to Show Cause over a one-month period from...
PRESS RELEASE

DEA Hosts 25th National Prescription Drug Take Back Day

WASHINGTON, DC – The Drug Enforcement Administration will host its 25th National Prescription Drug Take Back Day on Saturday, October 28, from 10 a.m. to 2 p.m. This event offers an easy, no-cost opportunity for the community to anonymously dispose of unneeded medications at nearly 5,000 local drop-off locations nationwide...
PRESS RELEASE

DEA Washington Division is Ready to Celebrate the 25th National Drug Take Back Day Across the DMV

Washington, DC – The Drug Enforcement Administration (DEA) will host its 25th National Prescription Drug Take Back Day on Saturday, October 28, from 10 a.m. to 2 p.m. in more than 300 collection sites across Maryland, District of Columbia, and Virginia (DMV). Through a collaborative effort with local law enforcement...
PRESS RELEASE

DEA Washington Division Holds Second Annual Family Summit on Fentanyl

WASHINGTON, DC – On October 6, the Drug Enforcement Administration (DEA) Washington Division hosted their 2nd Family Summit in support of those who have lost loved ones to fentanyl poisoning in the District of Columbia, Maryland, and Virginia. The Summit was very emotional and educational to all those who attended...
PRESS RELEASE

Former Chief Operating Officer of Area Pain Clinics Indicted

CHARLOTTESVLLE, Va. – A federal grand jury returned an indictment this week charging the former chief operating officer of area pain clinics with three conspiracy counts for her alleged involvement in health care fraud and illegal drug distribution. Jennifer Ann “Jen” Adams, 50, of Mount Pleasant, South Carolina, is charged...
PRESS RELEASE

DEA Holds Second Annual Family Summit on Fentanyl

WASHINGTON – On September 25 and 26, the U.S. Drug Enforcement Administration hosted the second annual DEA Family Summit on Fentanyl for families from across the country who have experienced the profound loss of a child due to a drug poisoning. U.S. Attorney General Merrick B. Garland and DEA Administrator...
PRESS RELEASE

19 Arrested on Federal Charges Trafficking Meth, Fentanyl, Heroin, and Cocaine in Charlottesville, VA

CHARLOTTESVILLE, Va. – A federal grand jury in Charlottesville, Virginia has indicted 17 individuals as part of a large-scale drug conspiracy that distributed more than 500 grams of methamphetamine, fentanyl, heroin, and cocaine in and around the Charlottesville region. The 37-count indictment, returned under seal August 29, 2023, partially unsealed...
PRESS RELEASE

DEA Washington Division Encourages Back to School Drug Awareness and Education

WASHINGTON, D.C. – As students return to school across the DMV, the DEA's Washington Division urges families to have open conversations about the dangers of drug experimentation and use. “Our citizens, especially our youth, are being exposed to an illicit drug supply that is more dangerous than ever before, making...
PRESS RELEASE

DEA Recognizes National Fentanyl Prevention and Awareness Day with Extended Hours for the Faces of Fentanyl Exhibit

WASHINGTON – The Drug Enforcement Administration recognizes National Fentanyl Prevention and Awareness Day by joining the dedicated voices who continue to raise awareness in an effort to prevent the fentanyl poisonings devastating families across the country. On Monday, August 21 the DEA Museum will open with extended hours from 6...
PRESS RELEASE

DEA Hosts Public Listening Sessions on Telemedicine Regulations

WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available...

Paginación

  • Primera página «
  • Anterior
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Current page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster